Rapport Therapeutics Inc....
(RAPP)
undefined
undefined%
At close: undefined
15.10
-19.85%
Pre-market Dec 16, 2024, 04:06 AM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 |
Revenue | - | - |
Cost of Revenue | 112.00K | 15.00K |
Gross Profit | -112.00K | -15.00K |
Operating Income | -36.18M | -10.37M |
Interest Income | 2.53M | - |
Pretax Income | -34.78M | -10.65M |
Net Income | -34.79M | -10.65M |
Selling & General & Admin | 8.07M | 1.24M |
Research & Development | 28.00M | 9.12M |
Other Expenses | - | - |
Operating Expenses | 36.07M | 10.35M |
Interest Expense | - | 285.00K |
Selling & Marketing Expenses | -112.00K | - |
Cost & Expenses | 36.18M | 10.37M |
Income Tax | 10.00K | - |
Shares Outstanding (Basic) | 164.35M | 36.58M |
Shares Outstanding (Diluted) | 164.35M | 36.58M |
EPS (Basic) | -0.21 | -0.29 |
EPS (Diluted) | -0.21 | -0.29 |
EBITDA | -34.66M | -10.35M |
Depreciation & Amortization | 112.00K | 15.00K |